COMMUNIQUÉS West-GlobeNewswire

OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Early Stage Prostate Cancer
02/07/2018
BATON ROUGE, La., July 02, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Summit Therapeutics plc : Holding(s) in Company
02/07/2018
TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : SUMMIT THERAPEUTICS PLC 1b. Please indicate if the [...]
Summit Therapeutics plc : Holding(s) in Company
02/07/2018
TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : SUMMIT THERAPEUTICS PLC 1b. Please indicate if the [...]
Alzheimer’s Foundation of America Awards College Scholarships to Students Impacted by Alzheimer’s Disease
02/07/2018
NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America recently awarded $30,000 in scholarships to 30 high school students from 25 states across the country who submitted essays for AFA’s [...]
Carp Cosmetic Surgery Center Now Offering CoolSculpting®
02/07/2018
The non-surgical body contouring procedure freezes away unwanted fat cells AKRON, Ohio, July 02, 2018 (GLOBE NEWSWIRE) -- Steven S. Carp, MD, of Carp Cosmetic Surgery Center offers patients and the community a non- [...]
Sanofi: Disclosure of trading in own shares
02/07/2018
Attachment Disclosure of trading in own shares (PDF).pdf
Sanofi : Déclaration des transactions sur actions propres
02/07/2018
Pièce jointe Déclaration des transactions sur actions propres (PDF).pdf
Ossur Hf : Transactions in relation to share buyback program
02/07/2018
Announcement no. 42/2018 Reykjavik, 02 July 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
VALNEVA Announces Significant Progress of its Lyme Disease Vaccine Candidate
02/07/2018
Valneva Announces Significant Progress of its Lyme Disease Vaccine Candidate Nantes, France, July 2, 2018 - Valneva SE ("Valneva" or "the Company"), a fully integrated, commercial stage biotech company focused on [...]
VALNEVA annonce des progrès significatifs pour son candidat vaccin contre la maladie de Lyme
02/07/2018
Valneva annonce des progrès significatifs pour son candidat vaccin contre la maladie de Lyme Nantes, France, 2 juillet 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée au développement, à [...]
NEOVACS : Reprise de cotation
02/07/2018
Paris et Boston, le 2 juillet 2018 - 17 : 45 pm CEST - Néovacs (Euronext Growth Paris : ALNEV), a demandé à Euronext Paris la reprise de la cotation de son titre (ISIN : FR0004032746), des bons de souscription d'actions [...]
NICOX : Number of voting riights as of June 30, 2018
02/07/2018
Nicox SA Société anonyme with a registered capital of € 29,588,510 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On July 2, 2018, MONTHLY PUBLICATION OF THE [...]
NICOX : Nombre de droits de vote au 30 juin 2018
02/07/2018
Nicox SA Société anonyme au capital de 29 588 510 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 2 juillet 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]
Intermountain Healthcare’s Leadership Institute Inaugural Class Begins in October
02/07/2018
Esteemed faculty is comprised of accomplished experts in healthcare, leadership, business, and academia. Salt Lake City, Utah, July 02, 2018 (GLOBE NEWSWIRE) -- Led by President and CEO Emeritus Charles W. Sorenson, MD [...]
Elsalys Biotech : New studies confirm anti-CD160 potential in ophthalmology
02/07/2018
New studies confirm anti-CD160 antibodies are potential therapeutics for ophthalmic diseases Efficacy and safety are consistently demonstrated in several in vivo preclinical models Anti-CD160 is a potent inhibitor of [...]
Publication of overall statement from the board of directors in respect of (a) the takeover offer made by Gefion Group Investments A/S and (b) the takeover offer made by Nordic Transport Group Holding A/S
02/07/2018
Company Announcement 2 July 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]
Oryzon to present at upcoming international conferences
02/07/2018
European Biotech Investor Day in NYC, New York, USA The Alzheimer's Association International Conference AAIC- 2018 – Chicago, USA MADRID, Spain and CAMBRIDGE, Mass., July 02, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics ( [...]
Greystone Skilled Nursing Centers Earn National AHCA Quality Awards
02/07/2018
TAMPA, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- Seven Greystone health and rehabilitation centers located throughout Florida are recipients of National Quality Awards by the American Health Care Association (AHCA) for [...]
NYMOX Announces Expanded Marketing Plans
02/07/2018
HASBROUCK HEIGHTS, N.J., July 02, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced today that following the recently announced increased manufacturing capabilities, the Company has [...]

Pages